Anticoagulation Reversal

Anticoagulation Reversal
Anticoagulation Reversal: Case 1 - Sensible Risk Stratification
Credits: .5 AMA PRA Category 1 credits™  |  .5 ANCC  |  .5 ACPE
Effective Date: August 15, 2017  |  Expiration Date: August 14, 2019
Format: Self Instructional - Audio Visual Voice-Over with Slides
Estimated Completion Time: 30 Minutes

This interactive case study discussion will provide the knowledge and tools to enable the primary care provider to use scoring systems such as the CHADS-VASc,and HAS-BLED to stratify patients risk potential for bleeding due to anticoagulation therapy.

Case: A 40-year old male from the Xinjiang Province in China presents with ischemic stroke, category 4 on the LAMS (Los Angeles Motor Scale). He is a crewmember on a Chinese freighter offloading in a U.S. port city when he collapses and is rushed to a local hospital. The captain has no information on the crewmember’s medical history but notes that the patient is a heavy smoker and tends to binge drink when portside.

Site Registration/Login Required. To participate select the appropriate profession below.
Anticoagulation Reversal Case 2
Anticoagulation Reversal: Case 2 - Converting Between Anticoagulants
Credits: .5 AMA PRA Category 1 credits™  |  .5 ANCC  |  .5 ACPE
Effective Date: August 15, 2017  |  Expiration Date: August 14, 2019
Format: Self Instructional - Audio Visual Voice-Over with Slides
Estimated Completion Time: 30 Minutes

This interactive case study discussion will provide the knowledge and tools to enable the primary care provider to explain the incidence and sources of bleeding related to the use of oral anticoagulants and its impact on health care; compare the difference in bleeding risk between oral vitamin K antagonists and direct oral anticoagulants (DOACs) and be able to convert from one anticoagulant to another.

Case: A 57-year old Alaska Native female has been taking Warfarin for several years for non-valvular AF and wishes to switch to one of the newer DOACs, which she hears are safer.

Site Registration/Login Required. To participate select the appropriate profession below.
Anticoagulation Reversal Case 3
Anticoagulation Reversal: Case 3 - Reversing Anticoagulation
Credits: .5 AMA PRA Category 1 credits™  |  .5 ANCC  |  .5 ACPE
Effective Date: August 15, 2017  |  Expiration Date: August 14, 2019
Format: Self Instructional - Audio Visual Voice-Over with Slides
Estimated Completion Time: 30 Minutes

This interactive case study discussion will provide the knowledge and tools to enable the primary care provider to understand the mechanism of anticoagulation and its reversal for oral vitamin K anticoagulants and the DOAC agents.

Case: An 82 year old male suffers a subdural hematoma after falling down a flight of concrete stairs. He is taking Warfarin. Past history remarkable for controlled HTN and diet-managed type 2 DM.

Site Registration/Login Required. To participate select the appropriate profession below.
Anticoagulation Reversal Case 4
Anticoagulation Reversal: Case 4 - Stopping the Bleed - A 4 Step Approach
Credits: .5 AMA PRA Category 1 credits™  |  .5 ANCC  |  .5 ACPE
Effective Date: August 15, 2017  |  Expiration Date: August 14, 2019
Format: Self Instructional - Audio Visual Voice-Over with Slides
Estimated Completion Time: 30 Minutes

This interactive case study discussion will provide the knowledge and tools to enable the primary care provider to understand the efficacy and limitations of current approaches to reversing anticoagulation in recipients of oral vitamin K antagonists and the mechanisms of the current reversal agents for DOACs and how they differ from approaches for reversal of vitamin K antagonists.

Case: A 59-year old male suffers a major GI bleed. He has been taking dabigatran for the past year for nonvalvular AF.

Site Registration/Login Required. To participate select the appropriate profession below.